Mutational spectra for polycyclic aromatic hydrocarbons in the supF target gene

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 450, Issue 1-2, 2000, Pages 75-93

  Bigger, C Anita H ^a   Pontén, Ingrid ^a   Page, John E ^a   Dipple, Anthony ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

1 NOP, 1 nitrosopyrene; 5,6 diMeChDE, 5,6 dimethylchrysene 1,2 dihydrodiol 3,4 epoxide; 5,6 Dimethylchrysene; 5 MeChDE, 5 methylchrysene 1,2 dihydrodiol 3,4 epoxide; 5 Methychrysene; 7 BrMe 12 MeBA, 7 bromomethyl 12 methylbenz a anthracene; 7 BrMeBA, 7 bromomethylbenz a anthracene; 7 Bromomethyl 12 methylbenz a anthracene; 7 Bromomethylbenz a anthracene; 7 MeBADE, 7 methylbenz a anthracene 3,4 dihydrodiol 1,2 epoxide; 7 Methylbenz a anthracene; AFB1, aflatoxin B1 8,9 epoxide; Benzo a pyrene; Benzo c phenanthrene; Benzo g chrysene; B a PDE, benzo a pyrene 7,8 dihydrodiol 9,10 epoxide; B c PhDE, benzo c phenanthrene 3,4 dihydrodiol 1,2 epoxide; B g ChDE, benzo g chrysene 11,12 dihydrodiol 13,14 epoxide; dAdo, deoxyadenosine; DE, dihydrodiol epoxide; DE 1, DE in which the benzylic hydroxyl and epoxide oxygen are cis (also referred to as syn); DE 2, DE in which the benzylic hydroxyl and epoxide oxygen are trans (also referred to as anti); dGuo, deoxyguanosine; Dihydrodiol epoxide; DNA adduct; N Aco AAF, N acetoxy 2 acetylaminofluorene; N AcO TFA AF, N acetoxy N trifluoroacetyl 2 aminofluorene; Polymerase stop assay; pS189; pSP189; Sequence specificity; Shuttle vector; Site specific mutagenesis; supF

Indexed keywords

5 METHYLCHRYSENE DIHYDRODIOL EPOXIDE; 5,6 DIMETHYLCHRYSENE DIHYDRODIOL EPOXIDE; 7 BROMOMETHYL 12 METHYLBENZ[A]ANTHRACENE; 7 BROMOMETHYLBENZ[A]ANTHRACENE; 7 METHYLBENZ[A]ANTHRACENE DIHYDRODIOL EPOXIDE; BENZO[A]PYRENE; BENZO[C]PHENANTHRENE 3,4 DIHYDRODIOL 1,2 EPOXIDE; BENZO[G]CHRYSENE DIHYDRODIOL EPOXIDE; CARCINOGEN; DEOXYADENOSINE; DEOXYGUANOSINE; DNA BASE; POLYCYCLIC AROMATIC HYDROCARBON; UNCLASSIFIED DRUG;

CHEMICAL CARCINOGENESIS; DNA ADDUCT; DNA SEQUENCE; GENE; GENE MUTATION; MUTATION; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RACEMIC MIXTURE; REVIEW; SHUTTLE VECTOR; SIMIAN VIRUS 40; SITE DIRECTED MUTAGENESIS; STEREOISOMERISM;

ANIMALS; BASE SEQUENCE; DNA; GENES, SUPPRESSOR; GENETIC VECTORS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; POINT MUTATION; POLYCYCLIC HYDROCARBONS, AROMATIC; RNA, TRANSFER; SEQUENCE DELETION;

EID: 0034732945     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(00)00017-8     Document Type: Article

References (77)

1. Miller E.C., Miller J.A. Mechanisms of chemical carcinogenesis: nature of proximate carcinogens and interactions with macromolecules. Pharm. Rev. 18:1966;805-838.
2. Miller J.A., Miller E.C. Chemical carcinogenesis: mechanism and approaches to its control. J. Natl. Cancer Inst. 47:1971;V-XIV.
3. Dipple A., Lawley P.D., Brookes P. Theory of tumour initiation by chemical carcinogens: dependence of activity on structure of ultimate carcinogen. Eur. J. Cancer. 4:1968;493-506.
4. Brookes P. Quantitative aspects of the reaction of some carcinogens with nucleic acids and the possible significance of such reactions in the process of carcinogenesis. Cancer Res. 26:1966;1994-2003.
5. Baird W.M., Pruess-Schwartz D. Polycyclic aromatic hydrocarbon-DNA adducts and their analysis: a powerful technique for characterization of pathways of metabolic activation of hydrocarbons to ultimate carcinogens. Yang S.K., Silverman B.D. Polycyclic Aromatic Hydrocarbon Carcinogenesis. 1988;141-179 CRC Press, Boca Raton, FL.
6. Irving C.C. Interaction of chemical carcinogens with DNA. Busch H. Methods in Cancer Research VII. 7th edn. 1973;189-244 Academic Press, New York.
7. McCann J., Choi E., Yamasaki E., Ames B. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc. Natl. Acad. Sci. U. S. A. 72:1975;5135-5139.
8. Brookes P., Lawley P.D. Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: relation between carcinogenic power of hydrocarbons and their binding to deoxyribonucleic acid. Nature. 202:1964;781-784.
9. Baird W.M., Dipple A., Grover P.L., Sims P., Brookes P. Studies on the formation of hydrocarbon-deoxyribonucleoside products by the binding of derivatives of 7-methylbenz[a]anthracene to DNA in aqueous solution and in mouse embryo cells in culture. Cancer Res. 33:1973;2386-2392.
10. Baird W.M, Brookes P. Isolation of the hydrocarbon-deoxyribonucleoside products from the DNA of mouse embryo cells treated in culture with 7-methylbenz[a]anthracene. Cancer Res. 33:1973;2378-2385.
11. Rayman M.P., Dipple A. Structure and activity in chemical carcinogenesis. Comparison of the reactions of 7-bromomethylbenz[a]anthracene and 7-bromomethyl-12-methylbenz[a]anthracene with mouse skin deoxyribonucleic acid in vivo. Biochemistry. 12:1973;1538-1542.
12. Sims P., Grover P.L., Swaisland A., Pal K., Hewer A. Metabolic activation of benzo[a]pyrene proceeds by a diol-epoxide. Nature. 252:1974;326-328.
13. Huberman E., Aspiras L., Heidelberger C., Grover P.L., Sims P. Mutagenicity to mammalian cells of epoxides and other derivatives of polycyclic hydrocarbons. Proc. Natl. Acad. Sci. U. S. A. 68:1971;3195-3199.
14. Baird W.M., Dipple A., Grover P.L., Sims P., Brookes P. Hydrocarbon-deoxyribonucleoside products formed by the binding of derivatives of 7-methylbenz[a]anthracene to DNA. Br. J. Cancer. 28:1973;84-85.
15. Buening M.K., Wislocki P.G., Levin W., Yagi H., Thakker D.R., Akagi H., Koreeda M., Jerina D.M., Conney A.H. Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (+)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene. Proc. Natl. Acad. Sci. U. S. A. 75:1978;5358-5361.
16. Levin W., Wood A.W., Chang R.L., Ittah Y., Croisy-Delcey M., Yagi H., Jerina D.M., Conney A.H. Exceptionally high tumor-initiating activity of benzo[c]phenanthrene bay region diol epoxides on mouse skin. Cancer Res. 40:1980;3910-3914.
17. Thakker D.R., Levin W., Yagi H., Yeh H.J.C., Ryan D.E., Thomas P.E., Conney A.H., Jerina D.M. Stereoselective metabolism of the (+)-(S, S)- and (-)-(R, R)-enantiomers of trans-3,4-dihydroxy-3,4-dihydrobenzo[c]phenanthrene by rat and mouse liver microsomes and by a purified and reconstituted cytochrome P-450 system. J. Biol. Chem. 261:1986;5404-5413.
18. Levin W., Chang R.L., Wood A., Thakker D.R., Yagi H., Jerina D.M., Conney A.H. Tumorigenicity of optical isomers of the diastereomeric bay region 3,4-diol 1,2-epoxides of benzo[c]phenanthrene in murine tumor models. Cancer Res. 46:1986;2257-2261.
19. Dipple A., Khan Q.A., Page J.E., Pontén I., Szeliga J. DNA reactions, mutagenic action and stealth properties of polycyclic aromatic hydrocarbon carcinogens. Int. J. Oncol. 14:1999;103-111.
20. Shih C., Shilo B.-Z., Goldfarb M.P., Dannenberg A., Weinberg R.A. Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc. Natl. Acad. Sci. U. S. A. 76:1979;5714-5718.
21. Peters G., Vousden K.H. Oncogenes and Tumour Suppressors. 1997;IRL Press, Oxford Univ. Press, New York.
22. Barbacid M. ras Genes. Annu. Rev. Biochem. 56:1987;779-827.
23. Seidman M.M., Dixon K., Razzaque A., Zagursky R.J., Berman M.L. A shuttle vector plasmid for studying carcinogen-induced point mutations in mammalian cells. Gene. 38:1985;233-237.
24. Drinkwater N.R., Klinedinst D.K. Chemically induced mutagenesis in a shuttle vector with a low background mutant frequency. Proc. Natl. Acad. Sci. U. S. A. 83:1986;3402-3406.
25. DuBridge R.B., Tang P., Hsia H.C., Leong P.-M., Miller J.H., Calos M.P. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7:1987;379-387.
26. Kraemer K.H., Seidman M.M. Use of supF, an Escherichia coli tyrosine suppressor tRNA gene, as a mutagenic target in shuttle-vector plasmids. Mutat. Res. 220:1989;61-72.
27. Bigger C.A.H., Strandberg J., Yagi H., Jerina D.M., Dipple A. Mutagenic specificity of a potent carcinogen, benzo[c]phenanthrene (4R,3S)-dihydrodiol (2S,1R)-epoxide, which reacts with adenine and guanine in DNA. Proc. Natl. Acad. Sci. U. S. A. 86:1989;2291-2295.
28. Bigger C.A.H., John J.St., Yagi H., Jerina D.M., Dipple A. Mutagenic specificities of four stereoisomeric benzo[c]phenanthrene dihydrodiol epoxides. Proc. Natl. Acad. Sci. U. S. A. 89:1992;368-372.
29. Bigger C.A.H., Flickinger D.J., Strandberg J., Pataki J., Harvey R.G., Dipple A. Mutational specificity of the anti 1,2-dihydrodiol 3,4-epoxide of 5-methylchrysene. Carcinogenesis. 11:1990;2263-2265.
30. Page J.E., Pataki J., Harvey R.G., Dipple A. Mutational specificity of the syn 1,2-dihydrodiol 3,4-epoxide of 5-methylchrysene. Cancer Lett. 110:1996;249-252.
31. Page J.E., Szeliga J., Amin S., Hecht S.S., Dipple A. Mutational spectra for 5,6-dimethylchrysene 1,2-dihydrodiol 3,4-epoxides in the supF gene of pSP189. Chem. Res. Toxicol. 8:1995;143-147.
32. Bigger C.A.H., Flickinger D.J., John J.St., Harvey R.G., Dipple A. Preferential mutagenesis at G:C base pairs by the anti 3,4-dihydrodiol 1,2-epoxide of 7-methylbenz[a]anthracene. Mol. Carcinog. 4:1991;176-179.
33. Szeliga J., Lee H., Harvey R.G., Page J.E., Ross H.L., Routledge M.N., Hilton B.D., Dipple A. Reaction with DNA and mutagenic specificity of syn-benzo[g]chrysene 11,12-dihydrodiol 13,14-epoxide. Chem. Res. Toxicol. 7:1994;420-427.
34. Szeliga J., Page J.E., Hilton B.D., Kieselyov A.S., Harvey R.G., Dunayevskiy Y.M., Vouros P., Dipple A. Characterization of DNA adducts formed by anti-benzo[g]chrysene 11,12-dihydrodiol 13,14-epoxide. Chem. Res. Toxicol. 8:1995;1014-1019.
35. Page J.E., Ross H.L., Bigger C.A.H., Dipple A. Mutagenic specificities and adduct distributions for 7-bromomethylbenz[a]anthracenes. Carcinogenesis. 17:1996;283-288.
36. Dipple A., Brookes P., Mackintosh D.S., Rayman M.P. Reaction of 7-bromomethylbenz[a]anthracene with nucleic acids, polynucleotides, and nucleosides. Biochemistry. 10:1971;4323-4330.
37. Ross H., Bigger C.A.H., Yagi H., Jerina D.M., Dipple A. Sequence specificity in the interaction of the four stereoisomeric benzo[c]phenanthrene dihydrodiol epoxides with the supF gene. Cancer Res. 53:1993;1273-1277.
38. Ross H.L., Lee H., Harvey R.G., Dipple A. Comparison of the sites of reaction of three polycyclic aromatic hydrocarbons in the supF gene. Mutat. Res. 306:1994;91-101.
39. Page J.E., Zajc B., Oh-Hara T., Lakshman M.K., Sayer J.M., Jerina D.M., Dipple A. Sequence context profoundly influences the mutagenic potency of trans-opened benzo[a]pyrene 7,8-diol 9,10-epoxide-purine nucleoside adducts in site-specific mutation studies. Biochemistry. 37:1998;9127-9137.
40. Page J.E., Pilcher A.S., Yagi H., Sayer J.M., Jerina D.M., Dipple A. Mutational consequences of replication of M13mp7L2 constructs containing cis-opened benzo[a]pyrene 7,8-diol 9,10-epoxide deoxyadenosine adducts. Chem. Res. Toxicol. 12:1999;258-263.
41. Pontén I., Sayer J.M., Pilcher A.S., Yagi H., Kumar S., Jerina D.M., Dipple A. Sequence context effects on mutational properties of cis-opened benzo[c]phenanthrene diol epoxide-deoxyadenosine adducts in site-specific mutation studies. Biochemistry. 38:1999;1144-1152.
42. Pontén I., Sayer J.M., Pilcher A.S., Yagi H., Kumar S., Jerina D.M., Dipple A. Factors determining mutagenic potential for individual cis and trans opened benzo[c]phenanthrene diol epoxide-deoxyadenosine adducts. Biochemistry. 2000;. in press.
43. Parris C.N., Seidman M.M. A signature element distinguishes sibling and independent mutations in a shuttle vector plasmid. Gene. 117:1992;1-5.
44. Routledge M.N., Wink D.A., Keefer L.K., Dipple A. Mutations induced by saturated aqueous nitric oxide in the pSP189 supF gene in human Ad293 and E. coli MBM7070 cells. Carcinogenesis. 14:1993;1251-1254.
45. 1-induced mutations in a plasmid replicated in xeroderma pigmentosum and DNA repair proficient human cells. Cancer Res. 52:1992;5668-5673.
46. Mah M.C.M., Boldt J., Culp S.J., Maher V.M., McCormick J.J. Replication of acetylaminofluorene-adducted plasmids in human cells: spectrum of base substitutions and evidence of excision repair. Proc. Natl. Acad. Sci. U. S. A. 88:1991;10193-10197.
47. Yang J.-L., Maher V.M., McCormick J.J. Kinds of mutation formed when a shuttle vector containing adducts of (+/-)-7β,8α-dihyroxy-9α,10α-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene replicates in human cells. Proc. Natl. Acad. Sci. U. S. A. 84:1987;3787-3791.
48. Maher V.M., Yang J.-L., Mah M.C.M., Wang Y.-C., Boldt J., McCormick J.J. Comparing the frequency and spectra of mutations induced when an SV40-based shuttle vector containing covalently bound residues of structurally related carcinogens replicates in human cells. Adv. Exp. Med. Biol. 283:1990;183-191.
49. Peltonen K., Hilton B.D., Pataki J., Lee H., Harvey R.G., Dipple A. Spectroscopic characterization of syn-5-methylchrysene 1,2-dihydrodiol 3,4-epoxide-deoxyribonucleoside adducts. Chem. Res. Toxicol. 4:1991;305-310.
50. Misra B., Amin S., Hecht S.S. Dimethylchrysene diol epoxides. Mutagenicity in Salmonella typhimurium, tumorigenicity in newborn mice, and reactivity with deoxyadenosine in DNA. Chem. Res. Toxicol. 5:1992;248-254.
51. Dipple A. Reactions of polycyclic aromatic hydrocarbons with DNA. Hemminki K., Dipple A., Shuker D.E.G., Kadlubar F.F., Segerbäck D., Bartsch H. IARC, DNA Adducts: Identification and Biological Significance. 1994;107-129 IARC, Lyon.
52. Agarwal R., Canella K.A., Yagi H., Jerina D.M., Dipple A. Benzo[c]phenanthrene-DNA adducts in mouse epidermis in relation to the tumorigenicities of four configurationally isomeric 3,4-dihydrodiol 1,2-epoxides. Chem. Res. Toxicol. 9:1996;586-592.
53. Sawicki J.T., Moschel R.C., Dipple A. Involvement of both syn- and anti-dihydrodiol-epoxides in the binding of 7,12-dimethylbenz[a]anthracene to DNA in mouse embryo cell cultures. Cancer Res. 43:1983;3212-3218.
54. Pruess-Schwartz D., Baird W.M., Yagi H., Jerina D.M., Pigott M.A., Dipple A. Stereochemical specificity in the metabolic activation of benzo[c]phenanthrene to metabolites that covalently bind to DNA in rodent embryo cell cultures. Cancer Res. 47:1987;4032-4037.
55. Lawrence C.W., Borden A., Banerjee S.K., LeClerc J.E. Mutation frequency and spectrum resulting from a single abasic site in a single-stranded vector. Nucleic Acids Res. 18:1990;2153-2157.
56. Foster P.L., Eisenstadt E., Miller J.H. Base substitution mutations induced by metabolically activated aflatoxin B1. Proc. Natl. Acad. Sci. U. S. A. 80:1983;2695-2698.
57. Loeb L.A., Preston B.D. Mutagenesis by apurinic/apyrimidinic sites. Annu. Rev. Genet. 20:1986;201-230.
58. Wilkins R.J. Site-specific analysis of drug interactions and damage in DNA using sequencing techniques. Anal. Biochem. 147:1985;267-279.
59. D'Andrea A.D., Haseltine W.A. Modification of DNA by aflatoxin B1 creates alkali-labile lesions in DNA at positions of guanine and adenine. Proc. Natl. Acad. Sci. U. S. A. 75:1978;4120-4124.
60. D'Andrea A.D., Haseltine W.A. Sequence specific cleavage of DNA by the antitumor antibiotics neocarzinostatin and bleomycin. Proc. Natl. Acad. Sci. U. S. A. 75:1978;3608-3612.
61. Bigger C.A.H., Cheh A., Latif F., Fishel R., Canella K.A., Stafford G.A., Yagi H., Jerina D.M., Dipple A. DNA strand breaks induced by configurationally isomeric hydrocarbon diol epoxides. Drug Metab. Rev. 26:1994;287-299.
62. Moore P.D., Strauss B.S. Sites of inhibition of in vitro DNA synthesis in carcinogen- and uv-treated ∅X174 DNA. Nature. 278:1979;664-666.
63. Reardon D.B., Bigger C.A.H., Strandberg J., Yagi H., Jerina D.M., Dipple A. Sequence selectivity in the reaction of optically active hydrocarbon dihydrodiol epoxides with rat H-ras DNA. Chem. Res. Toxicol. 2:1989;12-14.
64. Singer B., Essigmann J.M. Site-specific mutagenesis: retrospective and prospective. Carcinogenesis. 12:1991;949-955.
65. Loechler E.L. The role of adduct site-specific mutagenesis in understanding how carcinogen-DNA adducts cause mutations: perspective, prospects and problems. Carcinogenesis. 17:1996;895-902.
66. 2-Gua, the major adduct of activated benzo[a]pyrene, when studied in an Escherichia coli plasmid using site-directed methods. Carcinogenesis. 13:1992;1415-1425.
67. 2-Gua adduct of the (+)-anti-benzo[a]pyrene diol epoxide is capable of inducing G→A and G→C, in addition to G→T, mutations. Biochemistry. 34:1995;13545-13553.
68. 2-dG adduct of (+)-anti-B[a]PDE shows a dramatically different mutagenic specificity (predominantly G→A) in a 5′-CGT-3′ sequence context. Biochemistry. 36:1997;10256-10261.
69. Lavrukhin O.V., Lloyd R.S. Mutagenic replication in a human cell extract of DNAs containing site-specific and stereospecific benzo(a)pyrene-7,8-diol-9,10-epoxide DNA adducts placed on the leading and lagging strands. Cancer Res. 58:1998;887-891.
70. 2-dG adduct of (+)-anti-B[a]PDE induces G→A mutations in a 5′-AGA-3′ sequence context. Carcinogenesis. 20:1999;261-268.
71. Moriya M., Spiegel S., Fernandes A., Amin S., Liu T.M., Geacintov N., Grollman A.P. Fidelity of translesional synthesis past benzo[a]pyrene diol epoxide-2′-deoxyguanosine DNA adducts: marked effects of host cell, sequence context, and chirality. Biochemistry. 35:1996;16646-16651.
72. Hanrahan C.J., Bacolod M.D., Vyas R.R., Liu T., Geacintov N.E., Loechler E.L., Basu A.K. Sequence specific mutagenesis of the major (+)-anti-benzo[a]pyrene diol epoxide-DNA adduct at a mutational hot spot in vitro and in Escherichia coli cells. Chem. Res. Toxicol. 10:1997;369-377.
73. McNees A.G., O'Donnell M., Horton P.H., Kim H.Y., Kim S.J., Harris C.M., Harris T.M., Lloyd R.S. Lack of correlation between in vitro and in vivo replication of precisely defined benz[a]anthracene adducted DNAs. J. Biol. Chem. 272:1997;33211-33219.
74. 2-2′-deoxyguanosine adducts in Escherichia coli and simian kidney cells. Biochemistry. 37:1998;10164-10172.
75. Banerjee S.K., Christensen R.B., Lawrence C.W., LeClerc J.E. Frequency and spectrum of mutations produced by a single cis-syn thymine-thymine cyclobutane dimer in a single-stranded vector. Proc. Natl. Acad. Sci. U. S. A. 85:1988;8141-8145.
76. Banerjee S.K., Borden R.B., Christensen R.B., LeClerc J.E., Lawrence C.W. SOS-dependent replication past a single trans-syn T-T cyclobutane dimer gives a different mutation spectrum and increased error rate compared with replication past this lesion in uninduced cells. J. Bacteriol. 172:1990;2105-2112.
77. Seidman M.M. The development of transient SV40 based shuttle vectors for mutagenesis studies: problems and solutions. Mutat. Res. 220:1989;55-60.